Study Information
Locations
Not Specified
Clinical Trial FAQs
Information for patients and study volunteers, including frequently asked questions.
Description
The purpose of this project is to investigate how PAMF patients deliberate, decide, and act upon genetic counseling and testing to determine their personal risk for breast and ovarian cancer. An additional goal is to map the patient experience of those who test positive for genetic mutations and examine their surveillance and risk reduction practices. The outcomes of this project are intended to provide in-depth information on patients’ experiences and decision-making around genetic counseling and testing in the newly created PAMF clinical genetics program.
Funder
Palo Alto Medical Foundation
Related Studies
Coverage, Price, and Reimbursement for Multigene Tests for Cancer and Related Conditions
Our objective is to examine “coverage, price, and reimbursement” for multigene tests broadly and for cancer-related indications.
Investigator: Su-Ying Liang, Ph.D.
Implementing Universal Lynch Syndrome Screening Across Multiple Healthcare Systems: Identifying Strategies to Facilitate and Maintain Programs in Different Organizations Contexts
To describe and explain variations in Lynch syndrome (LS) screening implementation across healthcare systems and create a toolkit for implementing LS screening.
Investigators: Su-Ying Liang, Ph.D., External PI, Principal Investigator, Monique de Bruin, M.D., MPH
Precision Medicine for Multiple Sclerosis: Making It Work (MS-SHARE)
Develop an app that support access to clinical data and shared decision-making, predict disease course, and guide disease management.
Investigators: Xiaowei (Sherry) Yan, PhD, MS, J.B. Jones, PhD, MBA
Risk-Benefit Trade-Offs for Whole Genome Sequencing
Describe the clinical pathway of genetic testing at PAMF, and assess and obtain preliminary data on the use of genetic tests at PAMF.
Investigators: External PI, Principal Investigator, Su-Ying Liang, Ph.D.
Genetics and Comorbidity of Migraine
Identify common genetic variants for migraine to determine whether there are single nucleotide polymorphisms associated with migraine.